Retreatment with 24-week course of interferon-α for patients with chronic hepatitis C

International Hepatology Communications

Volumn 5, Issue 2, 1996, Pages 135-142

  Hagiwara, H ^a   Hayashi, N ^a   Oshita, M ^a   Katayama, K ^a   Kasahara, A ^a   Fusamoto, H ^a   Kamada, T ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

antiviral therapy; hepatitis C virus RNA; interferon therapy; level of viremia

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; ENDOGENOUS COMPOUND; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; MALE; PRIORITY JOURNAL; VIREMIA;

EID: 0029944370     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/0928-4346(96)00291-5     Document Type: Article

References (18)

1. H Hagiwara N Hayashi E Mita Detection of hepatitis C virus RNA in chronic non-A, non-B liver disease Gastroenterology 102 1992 692 694
2. N Yuki N Hayashi A Kasahara Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma Dig Dis Sci 37 1992 65 72
3. K Ikeda S Saitoh I Koida A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis Hepatology 18 1993 47 53
4. JH Hoofnagle KD Mullen DB Jones Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report N Engl J Med 315 1986 1575 1578
5. GL Davis LA Balart ER Schiff Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial N Engl J Med 321 1989 1501 1506
6. AM Di Bisceglie P Martin C Kassianides Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial N Engl J Med 321 1989 1506 1510
7. H Hagiwara N Hayashi E Mita Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α Hepatology 15 1992 37 41
8. H Hagiwara N Hayashi E Mita Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy Gastroenterology 104 1993 877 883
9. A Kasahara N Hayashi N Hiramatsu Ability of prolonged interferon treatment of suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial Hepatology 21 1995 291 297
10. H Okamoto Y Sugiyama S Okada Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources J Gen Virol 73 1992 673 679
11. E Mita N Hayashi H Hagiwara Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer Dig Dis Sci 39 1994 977 982
12. H Hagiwara N Hayashi E Mita Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease Hepatology 17 1993 545 550
13. JYN Lau GL Davis J Kniffen Significance of serum hepatitis C virus RNA levels in chronic hepatitis C Lancet 341 1993 1501 1504
14. K Yoshioka S Kakumu T Wakita Detection of hepatitis C virus by polymerase chain reaction and response to interferon therapy: relationship to genotypes of hepatitis C virus Hepatology 16 1992 293 299
15. S Okada Y Akahane H Suzuki The degree of variability in the amino terminal region of the E2 NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients Hepatology 16 1992 619 624
16. Y Kanazawa N Hayashi E Mita Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients Hepatology 20 1994 1121 1130
17. T Moribe N Hayashi Y Kanazawa Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy Gastroenterology 108 1995 789 795
18. A Tsubota K Chayama K Ikeda Factors predictive of response to interferon α therapy in hepatitis C virus infection Hepatology 19 1994 1088 1094